OCC-WCC 2024 | WCC數字醫療AI論壇：創新科技驅動心血管健康
*僅供醫學專業人士閱讀參考
隨著科技的日新月異，數字醫療與人工智慧正日益成為領域革新的關鍵動力。這些前沿技術不僅透過精準診斷、個性化治療和高效預防，深刻改變了心血管醫療的面貌，更為患者帶來了前所未有的就醫舒適度和便捷性。
第十八屆東方心臟病學會議（The 18th Oriental Congress of Cardiology，OCC 2024）與世界心臟病學大會（World Congress of Cardiology，WCC 2024），將於2024年6月27-30日在上海國際會議中心隆重召開。屆時，與會專家們將圍繞數字醫療與人工智慧在心血管領域的前沿應用展開深度對話，分享最新研究成果和實踐經驗，共同探索這一領域未來的無限可能和發展潛力。
With the rapid advancement of technology, digital healthcare and artificial intelligence are increasingly becoming crucial drivers of innovation in the field of cardiology. These cutting-edge technologies have profoundly transformed cardiovascular medicine through precise diagnosis, personalized treatment, and efficient prevention, while also bringing unprecedented comfort and convenience to patients.
The 18th Oriental Congress of Cardiology (OCC 2024) and the World Congress of Cardiology (WCC 2024) will be held grandly at the Shanghai International Convention Center from June 27 to 30, 2024. During this event, experts will engage in in-depth discussions on the frontier applications of digital healthcare and artificial intelligence in cardiology, share the latest research findings and practical experiences, and jointly explore the limitless possibilities and development potential of this field.
論壇時間：2024年6月29日 星期六
論壇地點：上海國際會議中心黃河廳
論壇壇主：悉尼大學Julie Redfern教授；張瑞巖教授
Forum Date:Saturday ,June 29, 2024 ；
Forum Venue:Yellow River Hall， Shanghai International Conference Centre
Forum Chairs:
Professor Julie Redfern, University of Sydney;
Professor Zhang Ruiyan, Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Julie Redfern教授
張瑞巖教授
數字醫療護“心”行
Digital Healthcare Heart Protection Initiative
隨著科技的飛速發展，數字醫療正日益成為心血管疾病防治的重要力量。悉尼大學Julie Redfern教授將詳細講解電子健康記錄（EHR）在心血管疾病（CVD）健康管理中的應用，透過高效的資料管理和精準的分析技術，極大地提升了診療效率。
與此同時，愛爾蘭國家預防和心血管健康研究所的Catriona Jennings教授將全面闡述預防心臟病學APP的開發與測試，藉助創新科技，使得心臟疾病的預防手段變得更加便捷、高效。隨後，北京大學閻麗靜教授則將細緻解讀中低收入國家基層醫療挑戰，並展示數字健康技術如何助力改善非傳染性疾病的防控與治療，為資源匱乏地區帶來福祉。
With the rapid development of technology, digital healthcare is increasingly becoming a significant force in the prevention and treatment of cardiovascular diseases. Professor Julie Redfern will elaborate on the application of electronic health records (EHR) in the health management of cardiovascular diseases (CVD), significantly enhancing diagnostic and therapeutic efficiency through efficient data management and precise analytical techniques.
Simultaneously, Professor Catriona Jennings will comprehensively expound on the development and testing of heart disease prevention apps, leveraging innovative technology to make heart disease prevention more convenient and efficient. Professor Yan Lijing, on the other hand, will provide a detailed interpretation of the challenges faced by primary healthcare in low- and middle-income countries, and demonstrate how digital health technology can assist in improving the prevention, control, and treatment of non-communicable diseases, bringing benefits to resource-scarce regions.
AI驅動心健康
AI-Driven Heart Health
在人工智慧（AI）的浪潮中，心血管領域正迎來一場革命性的變革。新加坡國立大學 Jasper Tromp教授將系統介紹AI在深度學習領域的機會與實踐，展示其在心血管健康資料解析中的巨大潛力。上海交通大學塗聖賢教授則將重點闡述AI技術在心血管診療過程中的應用，探討如何利用AI提高診療效率，為患者帶來更為精準、個性化的治療方案。
在心電圖這一心血管領域的重要工具中，倫敦帝國理工學院Fu Siong Ng教授將深入探討人工智慧在心電圖分析中的新興作用，闡述AI 如何助力醫生如何在複雜的心電圖資訊中迅速捕捉到關鍵資訊，為心血管疾病的早期診斷和精準治療提供有力支援。
In the wave of artificial intelligence (AI), the cardiovascular field is undergoing a revolutionary transformation. Professor Jasper Tromp will systematically introduce the opportunities and practices of AI in the field of deep learning, demonstrating its tremendous potential in analyzing cardiovascular health data. Professor Tu Shengxian will focus on elaborating the application of AI technology in the process of cardiovascular diagnosis and treatment, exploring how to utilize AI to improve diagnostic efficiency and provide patients with more precise and personalized treatment plans.
Regarding electrocardiogram (ECG), an essential tool in the cardiovascular field, Professor Fu Siong Ng will delve into the emerging role of artificial intelligence in ECG analysis, explaining how AI assists doctors in quickly capturing key information from complex ECG data, providing strong support for early diagnosis and precise treatment of cardiovascular diseases.
AI、數字雙驅，心血管未來可期！
AI and Digital Dual-Drivers: A Promising Future for Cardiovascular Health!
在人工智慧與數字技術的雙重驅動下，心血管醫療的未來發展方向正逐漸清晰。上海科技大學生物醫學工程學院創始院長沈定剛教授將在醫學成像領域深入探討全棧和全譜技術的應用，這些先進技術如何與人工智慧相結合，為心血管疾病的診斷和治療提供更全面、更精準的視覺輔助。
同時，新德里慢性病控制中心 BRIDGE 數字健康中心的負責人Arun P Jose教授將從全球視角出發，審視數字健康創新的現狀和未來，為我們提供寶貴的國際視野和實踐經驗，啟發新的思考，幫助更好地應對數字健康領域的發展挑戰，特別是在心血管疾病的預防、診斷和管理方面。
Driven by the dual forces of artificial intelligence and digital technology, the future development direction of cardiovascular healthcare is gradually becoming clearer. Professor Shen Dinggang will delve deeply into the application of full-stack and full-spectrum technologies in the field of medical imaging, exploring how these advanced technologies, combined with artificial intelligence, can provide more comprehensive and precise visual assistance for the diagnosis and treatment of cardiovascular diseases.
Meanwhile, Professor Arun P Jose will examine the current status and future of digital health innovation from a global perspective, particularly the challenges and opportunities faced by the cardiovascular field.
我們熱切地期盼著WCC-數字醫療與人工智慧論壇的盛大召開。期待在論壇上聆聽與會專家的深刻見解和精彩交流，共同挖掘數字醫療與人工智慧在心血管領域的無限潛力和創新機遇，為心血管疾病的防治貢獻智慧和力量！
We eagerly await the grand convening of the WCC-Digital Healthcare and Artificial Intelligence Forum. We look forward to listening to the insightful exchanges and brilliant discussions among the participating experts at the forum, and jointly exploring the unlimited potential and innovative opportunities of digital healthcare and artificial intelligence in the cardiovascular field, contributing wisdom and strength to the prevention and treatment of cardiovascular diseases!
歡迎註冊
會議時間：2024年6月27-30日
會議地點：上海國際會議中心
註冊官網：www.occmd.org
Conference Dates：June 27-30, 2024
Conference Venue：Shanghai International Convention Center
Registration Website：www.occmd.org
更多心血管精彩內容
快來“醫生站網頁版”瞧一瞧
精彩資訊等你來
稽核：張瑞巖、錢菊英、陸國 平、徐亞偉
責任編輯：葉子
*"醫學界"力求所發表內容專業、可靠，但不對內容的準確性做出承諾；請相關各方在採用或以此作 為決策依據時另行核查。